Review launched after Harvard psychiatrist failed to disclose industry funding

doi:10.1136/bmj.39609.364688.DB

BMJ 2008;336:1327 (14 June), doi:10.1136/bmj.39609.364688.DB

News

Review launched after Harvard psychiatrist failed to disclose industry funding

Jeanne Lenzer

¹ New York

The first 150 words of the full text of this article appear below.

Findings that a leading Harvard professor of psychiatry failedto report substantial payments that he received from drug companieshas caused Harvard Medical School, one of its affiliated hospitals,and the US National Institutes of Health (NIH) to come underfire.

An investigation by the US senator Charles Grassley showed thatthe psychiatrist, Joseph Biederman, and two of his colleagues,Thomas Spencer and Timothy Wilens, had altogether received morethan $4.2m (£2.1m; ${euro}$ 2.7m) from drug companies since 2000.

The financial disclosure forms filed by the three doctors, accordingto Mr Grassley, "were a mess" and made it seem that they hadreceived only "a couple of hundred thousand dollars" in thepast seven years (http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?dbname=2008_record&page=S5029&position=all).

Mr Grassley said that the failure of the researchers to reporttheir full income could place Harvard and Massachusetts GeneralHospital "in jeopardy of violating NIH regulations on conflictsof interest." Such violations . . . [Full text of this article]

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?